944329-18-4

Upstream product

• 179992-61-1 (2S,4aR,7R,7aR)-7-Azido-2-phenyl-tetrahydro-furo[3,2-d][1,3]dioxin-6-one 
• 15384-34-6 D-lyxono-1,4-lactone 
• 131614-82-9 3,5-O-(S)-benzylidene-D-lyxono-1,4-lactone 
• 100-52-7 benzaldehyde 

Downstream Products

• 944329-19-5 C₁₄H₁₉N₃O₈S₂ 
• 944329-21-9 C₁₂H₁₆N₄O₂ 
• 944329-20-8 C₂₀H₂₄N₄O₅S 
• 944329-24-2 N-((3S,4R,5S)-4-hydroxy-5-(hydroxymethyl)pyrrolidin-3-yl)acetamide 
• 868522-73-0 N-((3S,4R,5S)-1-benzyl-4-hydroxy-5-(hydroxymethyl)pyrrolidin-3-yl)acetamide 
• 944329-23-1 C₁₈H₂₄N₂O₅ 
• 944329-22-0 (2S,3R,4S)-4-amino-1-benzyl-2-(hydroxymethyl)pyrrolidin-3-ol 

Relevant academic research and scientific papers

Design and Synthesis of Orthogonally Protected D- and L-β-Hydroxyenduracididines from D-lyxono-1,4-Lactone

A practical synthesis of the orthogonally protected d- and l-β-hydroxyenduracididines (d- and l-βhEnds), the unique, nonproteinogenic α-amino acids found in mannopeptimycin antibiotics, is described. We appropriately applied d-lyxono-1,4-lactone derivativ

Efficient synthesis from d-lyxonolactone of 2-acetamido-1,4-imino-1,2,4-trideoxy-l-arabinitol LABNAc, a potent pyrrolidine inhibitor of hexosaminidases

The synthesis from d-lyxonolactone of 2-acetamido-1,4-imino-1,2,4-trideoxy-l-arabinitol LABNAc proceeded in an overall yield of 25%; the enantiomer, 2-acetamido-1,4-imino-1,2,4-trideoxy-d-arabinitol DABNAc, was prepared from l-lyxonolactone. LABNAc and N-